This brand name is authorized in Finland.
The drug VAMINOLAC contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
30KYC7MIAI - ASPARTIC ACID
|
2
|
UNII
OF5P57N2ZX - ALANINE
|
|
The alanine is an a-amino acid and the L-stereoisomer is one of the 24 protein amino acids encoded by the human genetic code. The a-carbon of alanine is a methyl group (-CH3). Based on this characteristic, alanine is classified as “non-polar” or “hydrophobic” amino acid. Also the methyl alanine is relatively chemically inert, which means that the alanine almost never involved in the functionality of the proteins, but is usually a structural part of the proteins, without being part of the “active site” of them. |
|
3
|
UNII
4QD397987E - HISTIDINE
|
4
|
UNII
47E5O17Y3R - PHENYLALANINE
|
5
|
UNII
8DUH1N11BX - TRYPTOPHAN
|
6
|
UNII
452VLY9402 - SERINE
|
7
|
UNII
3KX376GY7L - GLUTAMIC ACID
|
|
Glutamic acid is a non-essential aminoacid used in biosynthesis of proteins. Besides being a building block of proteins, glutamic acid plays a principal role in neural activation. Glutamate is also responsible for the umami (savory) flavor of certain foods. In medicine, glutamate is used as a metabolic supplemnet in patients undergoing coronary surgery. |
|
8
|
UNII
F7625B974U - LYSINE MONOHYDRATE
|
9
|
UNII
GMW67QNF9C - LEUCINE
|
10
|
UNII
HG18B9YRS7 - VALINE
|
11
|
UNII
AE28F7PNPL - METHIONINE
|
12
|
UNII
42HK56048U - TYROSINE
|
13
|
UNII
94ZLA3W45F - ARGININE
|
|
Arginine is an essential amino acid that is physiologically active in the L-form. It is commonly found as a component of total parenteral nutrition. |
|
14
|
UNII
K848JZ4886 - CYSTEINE
|
15
|
UNII
04Y7590D77 - ISOLEUCINE
|
16
|
UNII
2ZD004190S - THREONINE
|
17
|
UNII
TE7660XO1C - GLYCINE
|
18
|
UNII
1EQV5MLY3D - TAURINE
|
19
|
UNII
9DLQ4CIU6V - PROLINE
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| B05BA01 | Amino acids | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BA Solutions for parenteral nutrition |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 199695, 386443 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.